Tetralogy of fallot epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
_NOTOC_ | |||
{{Tetralogy of fallot}} | {{Tetralogy of fallot}} | ||
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh| Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org] | {{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh| Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org] | ||
==Overview== | ==Overview== | ||
Tetralogy of Fallot represents 5-7% of congenital heart | Tetralogy of Fallot represents 5-7% of [[congenital heart defect]]s. Tetralogy of Fallot is the most common cause of [[cyanotic heart disease]] and accounts for one third of all cases of [[cyanotic heart disease]]. | ||
==Epidemiology and | ==Epidemiology and Demographics== | ||
* Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births | * Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births | ||
* It represents 5-7% of congenital heart defects. | * It represents 5-7% of congenital heart defects. | ||
| Line 12: | Line 14: | ||
* The incidence in siblings is 1% to 5%. | * The incidence in siblings is 1% to 5%. | ||
== | ==Gender== | ||
* Tetralogy of Fallot occurs slightly more often in males than in females. | * Tetralogy of Fallot occurs slightly more often in males than in females. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{Congenital malformations and deformations of circulatory system}} | {{Congenital malformations and deformations of circulatory system}} | ||
| Line 38: | Line 33: | ||
[[uk:Тетрада Фалло]] | [[uk:Тетрада Фалло]] | ||
[[zh:法乐氏四联症]] | [[zh:法乐氏四联症]] | ||
[[Category:Disease]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
Revision as of 14:36, 4 October 2012
_NOTOC_
|
Tetralogy of fallot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
|
|
Tetralogy of fallot epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Tetralogy of fallot epidemiology and demographics |
|
Tetralogy of fallot epidemiology and demographics in the news |
|
Risk calculators and risk factors for Tetralogy of fallot epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]
Overview
Tetralogy of Fallot represents 5-7% of congenital heart defects. Tetralogy of Fallot is the most common cause of cyanotic heart disease and accounts for one third of all cases of cyanotic heart disease.
Epidemiology and Demographics
- Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births
- It represents 5-7% of congenital heart defects.
Genetics
- The majority of cases are thought to be sporadic and are not familial.
- The incidence in siblings is 1% to 5%.
Gender
- Tetralogy of Fallot occurs slightly more often in males than in females.
References
de:Fallot-Tetralogie it:Tetralogia di Fallot nl:Tetralogie van Fallot nn:Fallots tetrade uk:Тетрада Фалло